Filing Details
- Accession Number:
- 0000899243-22-035443
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-09 16:40:50
- Reporting Period:
- 2022-11-07
- Accepted Time:
- 2022-11-09 16:40:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-07 | 1,303 | $187.53 | 37,380 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-11-07 | 140 | $299.72 | 37,240 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 210 | $300.96 | 37,030 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 189 | $301.99 | 36,841 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 261 | $303.21 | 36,580 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 280 | $304.58 | 36,300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 140 | $305.39 | 36,160 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 83 | $306.57 | 36,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-11-07 | 1,303 | $0.00 | 1,303 | $187.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,304 | 2029-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $299.72 (range $299.46 to $299.97).
- Open market sales reported on this line occurred at a weighted average price of $300.96 (range $300.54 to $301.18).
- Open market sales reported on this line occurred at a weighted average price of $301.99 (range $301.84 to $302.20).
- Open market sales reported on this line occurred at a weighted average price of $303.21 (range $302.89 to $303.45).
- Open market sales reported on this line occurred at a weighted average price of $304.58 (range $304.14 to $304.91).
- Open market sales reported on this line occurred at a weighted average price of $305.39 (range $305.38 to $305.39).
- Open market sales reported on this line occurred at a weighted average price of $306.57 (range $306.45 to $307.22).
- The option vests in 16 quarterly installments from 2/6/2019.
Billionaire Hedge Funds
